CARLSBAD, Calif., Dec. 04, 2023 - Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the publication of the first 6-month clinical evaluation of its ZIP™ fusion implant in the Journal of Pain Research. Dr. Koga is a co-author and co-investigator in the ongoing REFINE study.
Dr. Sebastian Koga, a neurosurgeon from Covington, LA emphasized, “Our study demonstrates that the ZIP device provides a stable platform for posterior fusion. The patients go home the same day as the surgery and use less medications for chronic pain. I am happy to contribute objective clinical evidence to this area of spine surgery. In my practice I use the device as an adjuvant to most single-level decompressions.”
The ZIP System was 510(k) cleared by the FDA in 2013 and has been commercially available in multiple sizes in the US since 2014. With thousands of procedures already completed worldwide, the ZIP device is safe and effective in an outpatient setting.
